Skip to main content

Peer Review reports

From: AT-0174, a novel dual IDO1/TDO2 enzyme inhibitor, synergises with temozolomide to improve survival in an orthotopic mouse model of glioblastoma

Original Submission
19 Nov 2023 Submitted Original manuscript
15 Dec 2023 Reviewed Reviewer Report
28 Feb 2024 Author responded Author comments - Michael J. Bickerdike
Resubmission - Version 2
28 Feb 2024 Submitted Manuscript version 2
26 Jun 2024 Reviewed Reviewer Report - Lawrence Recht
28 Jun 2024 Reviewed Reviewer Report
8 Jul 2024 Author responded Author comments - Michael J. Bickerdike
Resubmission - Version 3
8 Jul 2024 Submitted Manuscript version 3
11 Jul 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
11 Jul 2024 Editorially accepted
24 Jul 2024 Article published 10.1186/s12885-024-12631-w

You can find further information about peer review here.

Back to article page